• 1
    Bieber EJ, Wood MB 1986 Bone reconstruction. Clin Plast Surg 13:645655.
  • 2
    Weitzel JN, Esterhai JL 1994 Delayed union nonunion, and synovial pseudoarthrosis. In: BrightonCT, FriedlaenderGE, LaneJM (eds.) Bone Formation and Repair. The American Academy of Orthopaedic Surgeons, Rosemont, Illinois, pp. 505528.
  • 3
    Kadiyala S, Hungnan L, Leong KW 1994 Biodegradable polymers as synthetic bone grafts. In: BrightonCT, FriedlaenderGE, LaneJM (eds.) Bone Formation and Repair. The American Academy of Orthopaedic Surgeons, Rosemont, Illinois, pp. 317324.
  • 4
    Ilizarov GA 1990 Clinical application of the tension-stress effect for limb lengthening. Clin Orthop 250:826.
  • 5
    Rajacich N, Bell DF, Armstrong PF 1992 Pediatric applications of the Ilizarov method. Clin Orthop 280:7280.
  • 6
    Crane GM, Ishaug SL, Mikos AG 1995 Bone tissue engineering. Nat Med 1:13221324.
  • 7
    Urist MR 1965 Bone: Formation by autoinduction. Science 150:893899.
  • 8
    Johnson EE, Urist MR, Finerman GA 1988 Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin Orthop 230:257265.
  • 9
    Johnson EE, Urist MR, Finerman GA 1990 Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP). Clin Orthop 250:234240.
  • 10
    Laurencin CT, Lane, JM 1994 Poly(lactic acid) and poly(glycolic acid): Orthopaedic surgery applications. In: BrightonCT, FriedlaenderGE, LaneJM (eds.) Bone Formation and Repair. The American Academy of Orthopaedic Surgeons, Rosemont, Illinois, pp. 325340.
  • 11
    Kawamura M, Urist MR 1988 Human fibrin is a physiologic delivery system for bone morphogenetic protein. Clin Orthop 235:302310.
  • 12
    Lucas PA, Laurencin C, Syftestad GT, Domb A, Goldberg VM, Caplan AI, Langer R 1990 Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a polyanhydride delivery vehicle. J Biomed Mater Res 24:901911.
  • 13
    Miyamoto S, Takaoka K, Okada T, Yoshikawa H, Hashimoto J, Suzuki S, Ono K 1992 Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. Clin Orthop 278:274285.
  • 14
    Urist MR, Nilsson O, Rasmussen J, Hirota W, Lovell T, Schmalzreid T, Finerman GA 1987 Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clin Orthop 214:295304.
  • 15
    Blau HM, Springer ML 1995 Gene therapy—A novel form of drug delivery. N Engl J Med 333:12041207.
  • 16
    Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P 1992 Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 90:626630.
  • 17
    Nakaoka T, Gonda K, Ogita T, Otawara-Hamamoto Y, Okabe F, Kira Y, Harii K, Miyazono K, Takuwa Y, Fujita T 1997 Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest 100:28242832.
  • 18
    Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, Saito I 1995 Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 23:38163821.
  • 19
    Kanegae Y, Makimura M, Saito I 1994 A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47:157166.
  • 20
    Yoshimura K, Kuzon WM, Harii K 1998 Myosin heavy chain expression in skeletal muscle autografts under neural or aneural conditions. J Surg Res 75:135147.
  • 21
    Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156159.
  • 22
    Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA 1988 Novel regulators of bone formation: Molecular clones and activities. Science 242:15281534.
  • 23
    Tso JY, Sun XH, Kao TH, Reece KS, Wu R 1985 Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:24852502.
  • 24
    Feng JQ, Harris MA, Ghosh-Choudhury N, Feng M, Mundy GR, Harris SE 1994 Structure and sequence of mouse bone morphogenetic protein-2 gene (BMP-2): Comparison of the structures and promoter regions of BMP-2 and BMP-4 genes. Biochim Biophys Acta 1218:221224.
  • 25
    ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, Heldin CH 1994 Characterization of type I receptors for transforming growth factor-beta and activin. Science 264:101104.
  • 26
    Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T, Yamada N, ten Dijke P, Miyazono K, Sakou T 1995 Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res 10:16511659.
  • 27
    Silberstein L, Webster SG, Travis M, Blau HM 1986 Developmental progression of myosin gene expression in cultured muscle cells. Cell 46:10751081.
  • 28
    Draber P, Slavickova A, Sladecek M, Viklicky V 1992 Monoclonal antibodies to Escherichia coli beta-galactosidase and their use for detection and purification of recombinant expression products. Hybridoma 11:385390.
  • 29
    Nicholson LV, Davison K, Falkous G, Harwood C, O'Donnell E, Slater CR, Harris JB 1989 Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody. J Neurol Sci 94:125136.
  • 30
    Nicholson LV, Davison K, Johnson MA, Slater CR, Young C, Bhattacharya S, Gardner-Medwin D, Harris JB 1989 Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci 94:137146.
  • 31
    Huard J, Lochmuller H, Acsadi G, Jani A, Massie B, Karpati G 1995 The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2:107115.
  • 32
    Schenk RK, Hunziker EB 1994 Histologic and ultrastructural features of fracture healing. In: BrightonCT, FriedlaenderGE, LaneJM (eds.) Bone Formation and Repair. The American Academy of Orthopaedic Surgeons, Rosemont, Illinois, pp. 117146.
  • 33
    Foster AH, Carlson BM 1980 Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesth Analg 59:727736.
  • 34
    Acsadi G, Jani A, Massie B, Simoneau M, Holland P, Blaschuk K, Karpati G 1994 A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet 3:579584.
  • 35
    Carlson BM, Faulkner JA 1983 The regeneration of skeletal muscle fibers following injury: A review. Med Sci Sports Exerc 15:187198.
  • 36
    Urist MR, DeLange RJ, Finerman GA 1983 Bone cell differentiation and growth factors. Science 220:680686.
  • 37
    Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S 1991 Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681687.
  • 38
    Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T 1994 Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblst lineage. J Cell Biol 127:17551766.
  • 39
    Harii K, Ohmori K, Sekiguchi J 1976 The free musculocutaneous flap. Plast Reconstr Surg 57:294303.
  • 40
    Mathes SJ, Nahai F 1979 Clinical Atlas of Muscle and Musculocutaneous Flaps. The CV Mosby Company, St. Louis, MO, U.S.A.